SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Analyst Ratings
USA - NASDAQ:SNSE - US81728A2078 - Common Stock
10.56 USD
+0.1 (+0.96%)
10.37 USD
-0.19 (-1.8%)
ChartMill assigns a Buy % Consensus number of 87% to SNSE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.15. This target is 213.92% above the current price.
SNSE was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about SNSE.
In the previous month the buy percentage consensus was at a similar level.
SNSE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | Citigroup | Reiterate | Buy -> Buy |
| 2024-05-24 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | Stephens & Co. | Initiate | Overweight |
| 2023-12-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-12-13 | Citigroup | Initiate | Buy |
| 2022-10-03 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-03-10 | Piper Sandler | Maintains | Overweight |
| 2021-07-01 | Berenberg | Downgrade | Buy -> Hold |
| 2021-06-29 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2021-03-01 | Oppenheimer | Initiate | Outperform |
| 2021-03-01 | Piper Sandler | Initiate | Overweight |
SENSEI BIOTHERAPEUTICS INC / SNSE FAQ
What do analysts expect the price target to be for SENSEI BIOTHERAPEUTICS INC (SNSE)?
9 analysts have analysed SNSE and the average price target is 33.15 USD. This implies a price increase of 213.92% is expected in the next year compared to the current price of 10.56.
Can you provide the consensus rating for SENSEI BIOTHERAPEUTICS INC stock?
The consensus rating for SENSEI BIOTHERAPEUTICS INC (SNSE) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.